Marc R Pritzker – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailpritz001umnedu

Research activity per year

5 Finished

5 results

Finished
A Phase 2, Randomized, Double-Blind, Placebo-Controlled,Parallel-Group, Multicenter, Dose Escalation and Proof-of-ConceptStudy to Evaluate the Safety and Efficacy of Razuprotafib inHospitalized Subjects With Moderate to Severe Coronavirus Disease
Pritzker, M. R. (PI)
AERPIO PHARMACEUTICALS, INC.
7/1/20 → 7/31/24
Project: Research project
A Phase 3 Open-label, Multicenter Study to Evaluate the
Pritzker, M. R. (PI)
LIQUIDIA TECHNOLOGIES, INC
2/8/18 → 3/28/22
Project: Research project
A Multicenter, Randomized, Double-blind, Placebo control
Pritzker, M. R. (PI)
IRONWOOD PHARMACEUTICALS, INC
1/1/18 → 1/30/21
Project: Research project
Pitch Heart Failure Study: Phosphodiesterase Type 5 Inhi
Pritzker, M. R. (PI)
NEW ENGLAND RESEARCH INSTITUTES, NATIONAL INSTITUTES OF HEALTH (NIH)
3/31/14 → 12/31/14
Project: Research project
Clinical Study to Determine Safety, Tolerability
Pritzker, M. R. (PI)
IKARIA THERAPEUTICS, LLC
8/1/12 → 7/31/19
Project: Research project